| 69.58 0.57 (0.83%) | 02-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 81.91  |
1-year : | 95.67 |
| Resists | First : | 70.12 |
Second : | 81.91 |
| Pivot price | 66.38 |
|||
| Supports | First : | 65.55 |
Second : | 62.72 |
| MAs | MA(5) : | 67.63 |
MA(20) : | 65.91 |
| MA(100) : | 62.62 |
MA(250) : | 71.96  |
|
| MACD | MACD : | 1 |
Signal : | 0.8 |
| %K %D | K(14,3) : | 83.8 |
D(3) : | 73.8 |
| RSI | RSI(14): 66.3 |
|||
| 52-week | High : | 90.04 | Low : | 57.25 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PBH ] has closed above the upper band by 8.0%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 48.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 70.24 - 70.52 | 70.52 - 70.81 |
| Low: | 67.83 - 68.12 | 68.12 - 68.42 |
| Close: | 69.1 - 69.61 | 69.61 - 70.13 |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Wed, 18 Feb 2026
Clear Eyes Supply Disruption Weighs on Prestige Consumer Healthcare Inc. (PBH)'s Quarterly Revenue - Finviz
Fri, 13 Feb 2026
Insider Sell: Jeffrey Zerillo Sells 1,000 Shares of Prestige Con - GuruFocus
Mon, 09 Feb 2026
How Mixed Q3 Results, Buybacks and Pillar5 Deal At Prestige (PBH) Have Changed Its Investment Story - Sahm
Thu, 05 Feb 2026
Prestige Consumer Healthcare (NYSE:PBH) Reports Mixed Q3 FY2026 Results, Misses Analyst Estimates - ChartMill
Thu, 05 Feb 2026
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot - WHAS11
Thu, 05 Feb 2026
Prestige Consumer Healthcare Q3 revenue tops estimates, narrows guidance - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 48 (M) |
| Shares Float | 48 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 110.8 (%) |
| Shares Short | 2,070 (K) |
| Shares Short P.Month | 2,140 (K) |
| EPS | 4.07 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 37.95 |
| Profit Margin | 18 % |
| Operating Margin | 29 % |
| Return on Assets (ttm) | 6.3 % |
| Return on Equity (ttm) | 11.2 % |
| Qtrly Rev. Growth | -3.5 % |
| Gross Profit (p.s.) | 13.14 |
| Sales Per Share | 23.08 |
| EBITDA (p.s.) | 7.77 |
| Qtrly Earnings Growth | -21.2 % |
| Operating Cash Flow | 263 (M) |
| Levered Free Cash Flow | 196 (M) |
| PE Ratio | 17.09 |
| PEG Ratio | 0 |
| Price to Book value | 1.83 |
| Price to Sales | 3.01 |
| Price to Cash Flow | 12.69 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|